Suppr超能文献

用铜绿假单胞菌免疫型5 O多糖-毒素A结合疫苗进行免疫接种:加强剂量对人体抗体水平的影响。

Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.

作者信息

Cryz S J, Sadoff J C, Fürer E

机构信息

Swiss Serum and Vaccine Institute, Berne.

出版信息

Infect Immun. 1988 Jul;56(7):1829-30. doi: 10.1128/iai.56.7.1829-1830.1988.

Abstract

Healthy adult volunteers were vaccinated on day 0 and 28 and at 15 months with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine. Immunization resulted in mild, transient local reactions in less than 20% of the subjects. Maximal immunoglobulin G (IgG) antibody titers to both toxin A and lipopolysaccharide (LPS) as determined by enzyme-linked immunosorbent assay were seen at day 42, at which time 50% of the vaccinees showed a fourfold or greater rise in toxin A-neutralizing titers. By 15 months postvaccination, both antitoxin A and anti-LPS IgG antibodies had markedly declined. A booster dose of vaccine administered at 15 months evoked a vigorous anti-toxin A IgG antibody response with 100% of the volunteers showing a fourfold or greater rise in neutralizing antibody titer compared with preimmunization levels. In contrast, there was no significant elevation of anti-LPS IgG antibody levels. At 24 months postimmunization, only anti-toxin A antibody levels were significantly higher than preimmunization levels.

摘要

健康成年志愿者在第0天、第28天和15个月时接种了铜绿假单胞菌免疫型5 O多糖-毒素A结合疫苗。免疫接种在不到20%的受试者中引发了轻微、短暂的局部反应。通过酶联免疫吸附测定法测定,在第42天时观察到针对毒素A和脂多糖(LPS)的最大免疫球蛋白G(IgG)抗体滴度,此时50%的接种者毒素A中和滴度升高了四倍或更高。到接种疫苗后15个月时,抗毒素A和抗LPS IgG抗体均显著下降。在15个月时给予一剂加强疫苗引发了强烈的抗毒素A IgG抗体反应,100%的志愿者中和抗体滴度与免疫前水平相比升高了四倍或更高。相比之下,抗LPS IgG抗体水平没有显著升高。免疫接种后24个月时,只有抗毒素A抗体水平显著高于免疫前水平。

相似文献

4
Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.
Infect Immun. 1986 Apr;52(1):161-5. doi: 10.1128/iai.52.1.161-165.1986.
10
Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Microb Pathog. 1989 Jan;6(1):75-80. doi: 10.1016/0882-4010(89)90010-7.

引用本文的文献

1
Vaccine Development: Lessons, Challenges, and Future Innovations.
Int J Mol Sci. 2025 Feb 25;26(5):2012. doi: 10.3390/ijms26052012.
2
: Recent Advances in Vaccine Development.
Vaccines (Basel). 2022 Jul 8;10(7):1100. doi: 10.3390/vaccines10071100.
4
Recent developments for Pseudomonas vaccines.
Hum Vaccin. 2011 Oct;7(10):999-1011. doi: 10.4161/hv.7.10.16369. Epub 2011 Oct 1.
6
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.
Infect Immun. 1996 Oct;64(10):4074-7. doi: 10.1128/iai.64.10.4074-4077.1996.

本文引用的文献

4
Infections caused by Pseudomonas aeruginosa.
Rev Infect Dis. 1983 Mar-Apr;5(2):279-313. doi: 10.1093/clinids/5.2.279.
6
Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
Lancet. 1980 Dec 13;2(8207):1263-5. doi: 10.1016/s0140-6736(80)92334-x.
7
Immunization against Pseudomonas in infection after thermal injury.
J Infect Dis. 1974 Nov;130 Suppl(0):S152-8. doi: 10.1093/infdis/130.supplement.s152.
8
A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Antibiot Chemother (1971). 1987;39:249-55. doi: 10.1159/000414350.
10
Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates.
Infect Immun. 1987 Jul;55(7):1547-51. doi: 10.1128/iai.55.7.1547-1551.1987.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验